Davis R M Inc. Trims Position in CME Group Inc. $CME

Davis R M Inc. decreased its position in CME Group Inc. (NASDAQ:CME) by 11.5% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 60,553 shares of the financial services provider’s stock after selling 7,846 shares during the quarter. Davis R M Inc.’s holdings in CME Group were worth $16,361,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in CME. Norges Bank bought a new position in shares of CME Group in the 2nd quarter worth approximately $1,571,447,000. Mawer Investment Management Ltd. raised its position in CME Group by 107.2% in the third quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider’s stock worth $406,029,000 after acquiring an additional 777,571 shares during the period. Viking Global Investors LP bought a new position in CME Group in the second quarter worth approximately $164,648,000. Vanguard Group Inc. boosted its stake in shares of CME Group by 1.5% during the 2nd quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock worth $9,695,313,000 after acquiring an additional 532,549 shares during the last quarter. Finally, Magellan Asset Management Ltd grew its position in shares of CME Group by 131,625.5% during the 2nd quarter. Magellan Asset Management Ltd now owns 486,067 shares of the financial services provider’s stock valued at $133,970,000 after acquiring an additional 485,698 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME reported record 2025 results: $6.5B in revenue, AD volume rose 6% to 28.1M contracts (commodities +12%, financials +5%), highlighting continued franchise growth and fee-related revenue strength. This earnings strength is the primary bullish catalyst. CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue
• Positive Sentiment: CME expanded physical-market infrastructure by approving the first aluminium warehousing facility in Taiwan, supporting commodities product growth and global market access for metals. That strengthens long-term fees and product diversification. CME approves first aluminium warehousing in Taiwan
• Neutral Sentiment: Intraday data and flow reports show mixed signals: QuiverQuant flagged heavy volume and both insider selling and sizable institutional position changes (some managers added, some trimmed). This suggests active rebalancing rather than a clear directional bet. $CME stock is up 2% today. Here’s what we see in our data.
• Neutral Sentiment: Reported short-interest data in the feed appears anomalous (zeros/NaN). No clear short-pressure signal is evident from that entry, so it shouldn’t be driving meaningful price moves. (Treat as data glitch/unreliable.)
• Negative Sentiment: CME experienced a brief technical glitch that halted metals and natural gas trading on Globex and briefly pressured the stock when markets reacted; trading was subsequently restarted. Operational reliability concerns can weigh on near-term sentiment until fully resolved. CME Group halts metals and natural gas trading on technical issues
• Negative Sentiment: Commentary criticizing CME’s Variable Storage Rate program (commodity storage economics) may pressure sentiment among some commodities market participants; impact is likely niche but could attract headlines. Why I Hate Variable Storage Rates

Insiders Place Their Bets

In related news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the sale, the chief executive officer directly owned 65,804 shares in the company, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Bryan T. Durkin sold 4,200 shares of the stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total value of $1,300,530.00. Following the transaction, the director directly owned 43,007 shares of the company’s stock, valued at approximately $13,317,117.55. The trade was a 8.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 30,248 shares of company stock worth $8,355,450. 0.30% of the stock is owned by corporate insiders.

CME Group Stock Up 1.0%

Shares of CME opened at $319.50 on Monday. The business’s 50 day moving average is $287.63 and its 200 day moving average is $275.99. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12-month low of $248.53 and a 12-month high of $322.57. The company has a market capitalization of $115.21 billion, a PE ratio of 28.63, a price-to-earnings-growth ratio of 3.74 and a beta of 0.24.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, topping the consensus estimate of $2.75 by $0.02. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period in the prior year, the company posted $2.52 EPS. Research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be issued a $1.30 dividend. The ex-dividend date is Tuesday, March 10th. This represents a $5.20 dividend on an annualized basis and a yield of 1.6%. This is an increase from CME Group’s previous quarterly dividend of $1.25. CME Group’s payout ratio is presently 44.80%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Jefferies Financial Group decreased their target price on CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a report on Monday, January 12th. Bank of America raised their price objective on CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. Piper Sandler boosted their price objective on CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Royal Bank Of Canada increased their target price on shares of CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a report on Thursday, February 5th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, CME Group presently has an average rating of “Hold” and a consensus price target of $299.53.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.